nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Vincristine—sarcoma	0.1	0.16	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Vincristine—sarcoma	0.1	0.16	CbGbCtD
Triazolam—CYP3A4—Thiotepa—sarcoma	0.099	0.158	CbGbCtD
Triazolam—CYP3A5—Vincristine—sarcoma	0.0751	0.12	CbGbCtD
Triazolam—CYP3A5—Etoposide—sarcoma	0.0689	0.11	CbGbCtD
Triazolam—CYP2C8—Etoposide—sarcoma	0.0662	0.106	CbGbCtD
Triazolam—CYP3A4—Mitoxantrone—sarcoma	0.0426	0.068	CbGbCtD
Triazolam—CYP3A4—Vincristine—sarcoma	0.0293	0.0468	CbGbCtD
Triazolam—CYP3A4—Etoposide—sarcoma	0.0268	0.0429	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—sarcoma	0.0183	0.0292	CbGbCtD
Triazolam—TSPO—hindlimb—sarcoma	0.00516	0.0821	CbGeAlD
Triazolam—TSPO—appendage—sarcoma	0.00443	0.0704	CbGeAlD
Triazolam—GABRP—mammary gland—sarcoma	0.00302	0.0481	CbGeAlD
Triazolam—GABRE—mammary gland—sarcoma	0.00231	0.0367	CbGeAlD
Triazolam—Thinking abnormal—Epirubicin—sarcoma	0.00179	0.00578	CcSEcCtD
Triazolam—Sweating increased—Etoposide—sarcoma	0.00179	0.00577	CcSEcCtD
Triazolam—Erythema—Thiotepa—sarcoma	0.00178	0.00574	CcSEcCtD
Triazolam—Glossitis—Epirubicin—sarcoma	0.00178	0.00574	CcSEcCtD
Triazolam—Erythema—Dactinomycin—sarcoma	0.00177	0.0057	CcSEcCtD
Triazolam—Tension—Thiotepa—sarcoma	0.00175	0.00564	CcSEcCtD
Triazolam—GABRR2—tendon—sarcoma	0.00174	0.0277	CbGeAlD
Triazolam—Dysarthria—Epirubicin—sarcoma	0.00174	0.00559	CcSEcCtD
Triazolam—Nervousness—Thiotepa—sarcoma	0.00173	0.00558	CcSEcCtD
Triazolam—Coordination abnormal—Epirubicin—sarcoma	0.00167	0.00539	CcSEcCtD
Triazolam—Thinking abnormal—Doxorubicin—sarcoma	0.00166	0.00535	CcSEcCtD
Triazolam—Glossitis—Doxorubicin—sarcoma	0.00165	0.00531	CcSEcCtD
Triazolam—Ill-defined disorder—Dactinomycin—sarcoma	0.00164	0.00529	CcSEcCtD
Triazolam—Agitation—Thiotepa—sarcoma	0.00164	0.00528	CcSEcCtD
Triazolam—GABRE—myometrium—sarcoma	0.00164	0.026	CbGeAlD
Triazolam—Dysarthria—Doxorubicin—sarcoma	0.00161	0.00517	CcSEcCtD
Triazolam—Stomatitis—Etoposide—sarcoma	0.0016	0.00515	CcSEcCtD
Triazolam—Jaundice—Etoposide—sarcoma	0.0016	0.00515	CcSEcCtD
Triazolam—Malaise—Dactinomycin—sarcoma	0.0016	0.00514	CcSEcCtD
Triazolam—Coordination abnormal—Doxorubicin—sarcoma	0.00155	0.00498	CcSEcCtD
Triazolam—Erythema—Mitoxantrone—sarcoma	0.00154	0.00496	CcSEcCtD
Triazolam—Hypertension—Thiotepa—sarcoma	0.00154	0.00496	CcSEcCtD
Triazolam—TSPO—myometrium—sarcoma	0.00153	0.0243	CbGeAlD
Triazolam—Anxiety—Thiotepa—sarcoma	0.00151	0.00487	CcSEcCtD
Triazolam—Dysgeusia—Mitoxantrone—sarcoma	0.00151	0.00486	CcSEcCtD
Triazolam—Discomfort—Dactinomycin—sarcoma	0.00149	0.00479	CcSEcCtD
Triazolam—GABRE—seminal vesicle—sarcoma	0.00148	0.0235	CbGeAlD
Triazolam—CYP2C8—mammary gland—sarcoma	0.00148	0.0235	CbGeAlD
Triazolam—TSPO—embryo—sarcoma	0.00147	0.0234	CbGeAlD
Triazolam—Confusional state—Thiotepa—sarcoma	0.00147	0.00473	CcSEcCtD
Triazolam—GABRG3—testis—sarcoma	0.00146	0.0232	CbGeAlD
Triazolam—Agitation—Vincristine—sarcoma	0.00145	0.00468	CcSEcCtD
Triazolam—Oedema—Dactinomycin—sarcoma	0.00144	0.00465	CcSEcCtD
Triazolam—Ill-defined disorder—Mitoxantrone—sarcoma	0.00143	0.0046	CcSEcCtD
Triazolam—Mental disability—Epirubicin—sarcoma	0.00143	0.00459	CcSEcCtD
Triazolam—Tachycardia—Thiotepa—sarcoma	0.00142	0.00457	CcSEcCtD
Triazolam—GABRP—uterus—sarcoma	0.00139	0.0221	CbGeAlD
Triazolam—GABRR1—testis—sarcoma	0.00139	0.0221	CbGeAlD
Triazolam—Malaise—Mitoxantrone—sarcoma	0.00139	0.00447	CcSEcCtD
Triazolam—Anorexia—Thiotepa—sarcoma	0.00139	0.00447	CcSEcCtD
Triazolam—TSPO—seminal vesicle—sarcoma	0.00138	0.022	CbGeAlD
Triazolam—Anorexia—Dactinomycin—sarcoma	0.00138	0.00443	CcSEcCtD
Triazolam—Hypertension—Vincristine—sarcoma	0.00137	0.0044	CcSEcCtD
Triazolam—Hypertension—Mitoxantrone—sarcoma	0.00133	0.00428	CcSEcCtD
Triazolam—Hepatic failure—Epirubicin—sarcoma	0.00133	0.00427	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—sarcoma	0.00132	0.00425	CcSEcCtD
Triazolam—CYP2C9—mammary gland—sarcoma	0.00131	0.0209	CbGeAlD
Triazolam—TSPO—hematopoietic system—sarcoma	0.00131	0.0209	CbGeAlD
Triazolam—Chest pain—Mitoxantrone—sarcoma	0.00131	0.00422	CcSEcCtD
Triazolam—Paraesthesia—Thiotepa—sarcoma	0.00131	0.00421	CcSEcCtD
Triazolam—Anxiety—Mitoxantrone—sarcoma	0.00131	0.00421	CcSEcCtD
Triazolam—Discomfort—Mitoxantrone—sarcoma	0.0013	0.00417	CcSEcCtD
Triazolam—Somnolence—Thiotepa—sarcoma	0.00129	0.00417	CcSEcCtD
Triazolam—Oedema—Vincristine—sarcoma	0.00129	0.00416	CcSEcCtD
Triazolam—Confusional state—Mitoxantrone—sarcoma	0.00127	0.00408	CcSEcCtD
Triazolam—Decreased appetite—Thiotepa—sarcoma	0.00127	0.00407	CcSEcCtD
Triazolam—TSPO—connective tissue—sarcoma	0.00126	0.0201	CbGeAlD
Triazolam—Oedema—Mitoxantrone—sarcoma	0.00126	0.00405	CcSEcCtD
Triazolam—Decreased appetite—Dactinomycin—sarcoma	0.00126	0.00404	CcSEcCtD
Triazolam—Fatigue—Thiotepa—sarcoma	0.00125	0.00404	CcSEcCtD
Triazolam—Dysgeusia—Etoposide—sarcoma	0.00125	0.00404	CcSEcCtD
Triazolam—Hyperhidrosis—Vincristine—sarcoma	0.00125	0.00402	CcSEcCtD
Triazolam—Fatigue—Dactinomycin—sarcoma	0.00125	0.00401	CcSEcCtD
Triazolam—Pain—Thiotepa—sarcoma	0.00124	0.00401	CcSEcCtD
Triazolam—Constipation—Thiotepa—sarcoma	0.00124	0.00401	CcSEcCtD
Triazolam—Shock—Mitoxantrone—sarcoma	0.00124	0.00398	CcSEcCtD
Triazolam—Pain—Dactinomycin—sarcoma	0.00124	0.00398	CcSEcCtD
Triazolam—Muscle spasms—Etoposide—sarcoma	0.00123	0.00397	CcSEcCtD
Triazolam—Anorexia—Vincristine—sarcoma	0.00123	0.00396	CcSEcCtD
Triazolam—GABRA4—tendon—sarcoma	0.00123	0.0195	CbGeAlD
Triazolam—Hepatic failure—Doxorubicin—sarcoma	0.00123	0.00395	CcSEcCtD
Triazolam—Tachycardia—Mitoxantrone—sarcoma	0.00123	0.00395	CcSEcCtD
Triazolam—Hyperhidrosis—Mitoxantrone—sarcoma	0.00122	0.00391	CcSEcCtD
Triazolam—GABRD—testis—sarcoma	0.00121	0.0192	CbGeAlD
Triazolam—Feeling abnormal—Thiotepa—sarcoma	0.0012	0.00386	CcSEcCtD
Triazolam—Anorexia—Mitoxantrone—sarcoma	0.0012	0.00386	CcSEcCtD
Triazolam—CYP3A7—liver—sarcoma	0.0012	0.019	CbGeAlD
Triazolam—Osteoarthritis—Epirubicin—sarcoma	0.00119	0.00384	CcSEcCtD
Triazolam—Feeling abnormal—Dactinomycin—sarcoma	0.00119	0.00383	CcSEcCtD
Triazolam—Gastrointestinal pain—Thiotepa—sarcoma	0.00119	0.00383	CcSEcCtD
Triazolam—Ill-defined disorder—Etoposide—sarcoma	0.00119	0.00383	CcSEcCtD
Triazolam—Gastrointestinal pain—Dactinomycin—sarcoma	0.00118	0.0038	CcSEcCtD
Triazolam—Affect lability—Epirubicin—sarcoma	0.00117	0.00378	CcSEcCtD
Triazolam—Insomnia—Vincristine—sarcoma	0.00117	0.00376	CcSEcCtD
Triazolam—Paraesthesia—Vincristine—sarcoma	0.00116	0.00373	CcSEcCtD
Triazolam—TSPO—smooth muscle tissue—sarcoma	0.00116	0.0184	CbGeAlD
Triazolam—Malaise—Etoposide—sarcoma	0.00116	0.00372	CcSEcCtD
Triazolam—Abdominal pain—Thiotepa—sarcoma	0.00115	0.00371	CcSEcCtD
Triazolam—GABRB3—connective tissue—sarcoma	0.00115	0.0183	CbGeAlD
Triazolam—Abdominal pain—Dactinomycin—sarcoma	0.00114	0.00368	CcSEcCtD
Triazolam—TSPO—skin of body—sarcoma	0.00114	0.0182	CbGeAlD
Triazolam—Mood swings—Epirubicin—sarcoma	0.00113	0.00364	CcSEcCtD
Triazolam—Paraesthesia—Mitoxantrone—sarcoma	0.00113	0.00363	CcSEcCtD
Triazolam—Loss of consciousness—Etoposide—sarcoma	0.00113	0.00363	CcSEcCtD
Triazolam—Decreased appetite—Vincristine—sarcoma	0.00112	0.00361	CcSEcCtD
Triazolam—Ataxia—Epirubicin—sarcoma	0.00112	0.00361	CcSEcCtD
Triazolam—GABRA5—testis—sarcoma	0.00112	0.0178	CbGeAlD
Triazolam—Dyspnoea—Mitoxantrone—sarcoma	0.00112	0.00361	CcSEcCtD
Triazolam—Somnolence—Mitoxantrone—sarcoma	0.00112	0.0036	CcSEcCtD
Triazolam—Fatigue—Vincristine—sarcoma	0.00111	0.00358	CcSEcCtD
Triazolam—Hypertension—Etoposide—sarcoma	0.00111	0.00356	CcSEcCtD
Triazolam—Constipation—Vincristine—sarcoma	0.0011	0.00355	CcSEcCtD
Triazolam—Pain—Vincristine—sarcoma	0.0011	0.00355	CcSEcCtD
Triazolam—Osteoarthritis—Doxorubicin—sarcoma	0.0011	0.00355	CcSEcCtD
Triazolam—Decreased appetite—Mitoxantrone—sarcoma	0.00109	0.00352	CcSEcCtD
Triazolam—Chest pain—Etoposide—sarcoma	0.00109	0.00351	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—sarcoma	0.00109	0.0035	CcSEcCtD
Triazolam—Fatigue—Mitoxantrone—sarcoma	0.00108	0.00349	CcSEcCtD
Triazolam—Discomfort—Etoposide—sarcoma	0.00108	0.00347	CcSEcCtD
Triazolam—Pain—Mitoxantrone—sarcoma	0.00107	0.00346	CcSEcCtD
Triazolam—Constipation—Mitoxantrone—sarcoma	0.00107	0.00346	CcSEcCtD
Triazolam—Hypersensitivity—Thiotepa—sarcoma	0.00107	0.00345	CcSEcCtD
Triazolam—GABRE—cardiac atrium—sarcoma	0.00107	0.017	CbGeAlD
Triazolam—Hypersensitivity—Dactinomycin—sarcoma	0.00106	0.00343	CcSEcCtD
Triazolam—Gastrointestinal pain—Vincristine—sarcoma	0.00106	0.0034	CcSEcCtD
Triazolam—Confusional state—Etoposide—sarcoma	0.00105	0.00339	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—sarcoma	0.00105	0.00339	CcSEcCtD
Triazolam—GABRR2—lymph node—sarcoma	0.00105	0.0166	CbGeAlD
Triazolam—Mood swings—Doxorubicin—sarcoma	0.00105	0.00337	CcSEcCtD
Triazolam—Asthenia—Thiotepa—sarcoma	0.00104	0.00336	CcSEcCtD
Triazolam—GABRA3—testis—sarcoma	0.00104	0.0166	CbGeAlD
Triazolam—Ataxia—Doxorubicin—sarcoma	0.00104	0.00334	CcSEcCtD
Triazolam—Asthenia—Dactinomycin—sarcoma	0.00104	0.00334	CcSEcCtD
Triazolam—Feeling abnormal—Mitoxantrone—sarcoma	0.00104	0.00334	CcSEcCtD
Triazolam—Pruritus—Thiotepa—sarcoma	0.00103	0.00332	CcSEcCtD
Triazolam—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00103	0.00331	CcSEcCtD
Triazolam—Tachycardia—Etoposide—sarcoma	0.00102	0.00329	CcSEcCtD
Triazolam—Abdominal pain—Vincristine—sarcoma	0.00102	0.00329	CcSEcCtD
Triazolam—CYP3A7-CYP3A51P—liver—sarcoma	0.00102	0.0162	CbGeAlD
Triazolam—Hyperhidrosis—Etoposide—sarcoma	0.00101	0.00325	CcSEcCtD
Triazolam—TSPO—cardiac atrium—sarcoma	0.000997	0.0159	CbGeAlD
Triazolam—Anorexia—Etoposide—sarcoma	0.000997	0.00321	CcSEcCtD
Triazolam—Diarrhoea—Thiotepa—sarcoma	0.000996	0.00321	CcSEcCtD
Triazolam—Abdominal pain—Mitoxantrone—sarcoma	0.000994	0.0032	CcSEcCtD
Triazolam—TSPO—uterus—sarcoma	0.000992	0.0158	CbGeAlD
Triazolam—Diarrhoea—Dactinomycin—sarcoma	0.000988	0.00318	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—sarcoma	0.000973	0.00313	CcSEcCtD
Triazolam—Dysuria—Epirubicin—sarcoma	0.000964	0.0031	CcSEcCtD
Triazolam—Dizziness—Thiotepa—sarcoma	0.000963	0.0031	CcSEcCtD
Triazolam—Hypersensitivity—Vincristine—sarcoma	0.000951	0.00306	CcSEcCtD
Triazolam—Paraesthesia—Etoposide—sarcoma	0.000939	0.00302	CcSEcCtD
Triazolam—Dyspnoea—Etoposide—sarcoma	0.000932	0.003	CcSEcCtD
Triazolam—GABRE—tendon—sarcoma	0.000931	0.0148	CbGeAlD
Triazolam—Somnolence—Etoposide—sarcoma	0.00093	0.00299	CcSEcCtD
Triazolam—Hypersensitivity—Mitoxantrone—sarcoma	0.000926	0.00298	CcSEcCtD
Triazolam—Asthenia—Vincristine—sarcoma	0.000926	0.00298	CcSEcCtD
Triazolam—Vomiting—Thiotepa—sarcoma	0.000926	0.00298	CcSEcCtD
Triazolam—TSPO—lymphoid tissue—sarcoma	0.000925	0.0147	CbGeAlD
Triazolam—Drowsiness—Epirubicin—sarcoma	0.000919	0.00296	CcSEcCtD
Triazolam—Vomiting—Dactinomycin—sarcoma	0.000919	0.00296	CcSEcCtD
Triazolam—Dermatitis—Thiotepa—sarcoma	0.000917	0.00295	CcSEcCtD
Triazolam—Headache—Thiotepa—sarcoma	0.000912	0.00294	CcSEcCtD
Triazolam—Decreased appetite—Etoposide—sarcoma	0.000909	0.00293	CcSEcCtD
Triazolam—Asthenia—Mitoxantrone—sarcoma	0.000902	0.0029	CcSEcCtD
Triazolam—Fatigue—Etoposide—sarcoma	0.000901	0.0029	CcSEcCtD
Triazolam—CYP2C8—hematopoietic system—sarcoma	0.000901	0.0143	CbGeAlD
Triazolam—Stomatitis—Epirubicin—sarcoma	0.000896	0.00288	CcSEcCtD
Triazolam—Jaundice—Epirubicin—sarcoma	0.000896	0.00288	CcSEcCtD
Triazolam—Constipation—Etoposide—sarcoma	0.000894	0.00288	CcSEcCtD
Triazolam—Pain—Etoposide—sarcoma	0.000894	0.00288	CcSEcCtD
Triazolam—Dysuria—Doxorubicin—sarcoma	0.000892	0.00287	CcSEcCtD
Triazolam—Diarrhoea—Vincristine—sarcoma	0.000883	0.00284	CcSEcCtD
Triazolam—TSPO—tendon—sarcoma	0.000869	0.0138	CbGeAlD
Triazolam—Nausea—Thiotepa—sarcoma	0.000865	0.00278	CcSEcCtD
Triazolam—Feeling abnormal—Etoposide—sarcoma	0.000862	0.00277	CcSEcCtD
Triazolam—Diarrhoea—Mitoxantrone—sarcoma	0.00086	0.00277	CcSEcCtD
Triazolam—Nausea—Dactinomycin—sarcoma	0.000858	0.00276	CcSEcCtD
Triazolam—Gastrointestinal pain—Etoposide—sarcoma	0.000855	0.00275	CcSEcCtD
Triazolam—Dizziness—Vincristine—sarcoma	0.000854	0.00275	CcSEcCtD
Triazolam—GABRB2—testis—sarcoma	0.000851	0.0135	CbGeAlD
Triazolam—Drowsiness—Doxorubicin—sarcoma	0.00085	0.00274	CcSEcCtD
Triazolam—TSPO—bone marrow—sarcoma	0.000842	0.0134	CbGeAlD
Triazolam—Stomatitis—Doxorubicin—sarcoma	0.000829	0.00267	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—sarcoma	0.000829	0.00267	CcSEcCtD
Triazolam—Abdominal pain—Etoposide—sarcoma	0.000827	0.00266	CcSEcCtD
Triazolam—Vomiting—Vincristine—sarcoma	0.000821	0.00264	CcSEcCtD
Triazolam—CYP3A5—hematopoietic system—sarcoma	0.000813	0.0129	CbGeAlD
Triazolam—Dermatitis—Vincristine—sarcoma	0.000813	0.00262	CcSEcCtD
Triazolam—Headache—Vincristine—sarcoma	0.000809	0.0026	CcSEcCtD
Triazolam—CYP2C9—hematopoietic system—sarcoma	0.0008	0.0127	CbGeAlD
Triazolam—Vomiting—Mitoxantrone—sarcoma	0.000799	0.00257	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—sarcoma	0.000795	0.00256	CcSEcCtD
Triazolam—Dermatitis—Mitoxantrone—sarcoma	0.000792	0.00255	CcSEcCtD
Triazolam—Headache—Mitoxantrone—sarcoma	0.000788	0.00254	CcSEcCtD
Triazolam—GABRE—testis—sarcoma	0.000771	0.0123	CbGeAlD
Triazolam—Hypersensitivity—Etoposide—sarcoma	0.00077	0.00248	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—sarcoma	0.000769	0.00248	CcSEcCtD
Triazolam—Nausea—Vincristine—sarcoma	0.000767	0.00247	CcSEcCtD
Triazolam—Asthenia—Etoposide—sarcoma	0.00075	0.00242	CcSEcCtD
Triazolam—Nausea—Mitoxantrone—sarcoma	0.000747	0.0024	CcSEcCtD
Triazolam—Pruritus—Etoposide—sarcoma	0.00074	0.00238	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—sarcoma	0.000736	0.00237	CcSEcCtD
Triazolam—TSPO—testis—sarcoma	0.00072	0.0114	CbGeAlD
Triazolam—Erythema—Epirubicin—sarcoma	0.000718	0.00231	CcSEcCtD
Triazolam—Diarrhoea—Etoposide—sarcoma	0.000715	0.0023	CcSEcCtD
Triazolam—Tinnitus—Doxorubicin—sarcoma	0.000712	0.00229	CcSEcCtD
Triazolam—Flatulence—Epirubicin—sarcoma	0.000708	0.00228	CcSEcCtD
Triazolam—Tension—Epirubicin—sarcoma	0.000705	0.00227	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—sarcoma	0.000703	0.00226	CcSEcCtD
Triazolam—Nervousness—Epirubicin—sarcoma	0.000698	0.00225	CcSEcCtD
Triazolam—Dizziness—Etoposide—sarcoma	0.000691	0.00223	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—sarcoma	0.00069	0.00222	CcSEcCtD
Triazolam—TSPO—liver—sarcoma	0.00068	0.0108	CbGeAlD
Triazolam—Ill-defined disorder—Epirubicin—sarcoma	0.000666	0.00215	CcSEcCtD
Triazolam—Vomiting—Etoposide—sarcoma	0.000665	0.00214	CcSEcCtD
Triazolam—Erythema—Doxorubicin—sarcoma	0.000664	0.00214	CcSEcCtD
Triazolam—Agitation—Epirubicin—sarcoma	0.00066	0.00213	CcSEcCtD
Triazolam—Dermatitis—Etoposide—sarcoma	0.000659	0.00212	CcSEcCtD
Triazolam—Headache—Etoposide—sarcoma	0.000655	0.00211	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—sarcoma	0.000655	0.00211	CcSEcCtD
Triazolam—GABRB3—testis—sarcoma	0.000653	0.0104	CbGeAlD
Triazolam—Tension—Doxorubicin—sarcoma	0.000652	0.0021	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—sarcoma	0.000651	0.0021	CcSEcCtD
Triazolam—Malaise—Epirubicin—sarcoma	0.000648	0.00209	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—sarcoma	0.000645	0.00208	CcSEcCtD
Triazolam—Syncope—Epirubicin—sarcoma	0.000644	0.00207	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—sarcoma	0.000639	0.00206	CcSEcCtD
Triazolam—Palpitations—Epirubicin—sarcoma	0.000635	0.00204	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—sarcoma	0.000631	0.00203	CcSEcCtD
Triazolam—Nausea—Etoposide—sarcoma	0.000621	0.002	CcSEcCtD
Triazolam—Hypertension—Epirubicin—sarcoma	0.00062	0.002	CcSEcCtD
Triazolam—GABRB3—liver—sarcoma	0.000618	0.00982	CbGeAlD
Triazolam—Ill-defined disorder—Doxorubicin—sarcoma	0.000617	0.00199	CcSEcCtD
Triazolam—Chest pain—Epirubicin—sarcoma	0.000611	0.00197	CcSEcCtD
Triazolam—Agitation—Doxorubicin—sarcoma	0.000611	0.00197	CcSEcCtD
Triazolam—CYP3A4—hematopoietic system—sarcoma	0.00061	0.0097	CbGeAlD
Triazolam—Anxiety—Epirubicin—sarcoma	0.000609	0.00196	CcSEcCtD
Triazolam—Discomfort—Epirubicin—sarcoma	0.000604	0.00195	CcSEcCtD
Triazolam—Malaise—Doxorubicin—sarcoma	0.000599	0.00193	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—sarcoma	0.000598	0.00193	CcSEcCtD
Triazolam—Syncope—Doxorubicin—sarcoma	0.000596	0.00192	CcSEcCtD
Triazolam—Confusional state—Epirubicin—sarcoma	0.000591	0.0019	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—sarcoma	0.000587	0.00189	CcSEcCtD
Triazolam—Oedema—Epirubicin—sarcoma	0.000586	0.00189	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—sarcoma	0.000584	0.00188	CcSEcCtD
Triazolam—Shock—Epirubicin—sarcoma	0.000577	0.00186	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—sarcoma	0.000574	0.00185	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—sarcoma	0.000572	0.00184	CcSEcCtD
Triazolam—Hyperhidrosis—Epirubicin—sarcoma	0.000567	0.00182	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—sarcoma	0.000566	0.00182	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—sarcoma	0.000564	0.00182	CcSEcCtD
Triazolam—GABRA2—lymph node—sarcoma	0.000563	0.00896	CbGeAlD
Triazolam—Discomfort—Doxorubicin—sarcoma	0.000559	0.0018	CcSEcCtD
Triazolam—GABRE—lymph node—sarcoma	0.000559	0.00888	CbGeAlD
Triazolam—Anorexia—Epirubicin—sarcoma	0.000559	0.0018	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—sarcoma	0.000553	0.00178	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—sarcoma	0.000547	0.00176	CcSEcCtD
Triazolam—Oedema—Doxorubicin—sarcoma	0.000542	0.00175	CcSEcCtD
Triazolam—Shock—Doxorubicin—sarcoma	0.000534	0.00172	CcSEcCtD
Triazolam—Insomnia—Epirubicin—sarcoma	0.00053	0.00171	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—sarcoma	0.000529	0.0017	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—sarcoma	0.000526	0.00169	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—sarcoma	0.000524	0.00169	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—sarcoma	0.000523	0.00168	CcSEcCtD
Triazolam—TSPO—lymph node—sarcoma	0.000522	0.00829	CbGeAlD
Triazolam—Somnolence—Epirubicin—sarcoma	0.000521	0.00168	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—sarcoma	0.000517	0.00166	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—sarcoma	0.00051	0.00164	CcSEcCtD
Triazolam—Fatigue—Epirubicin—sarcoma	0.000505	0.00163	CcSEcCtD
Triazolam—Constipation—Epirubicin—sarcoma	0.000501	0.00161	CcSEcCtD
Triazolam—Pain—Epirubicin—sarcoma	0.000501	0.00161	CcSEcCtD
Triazolam—CYP2C8—testis—sarcoma	0.000494	0.00785	CbGeAlD
Triazolam—Insomnia—Doxorubicin—sarcoma	0.000491	0.00158	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—sarcoma	0.000487	0.00157	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—sarcoma	0.000484	0.00156	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—sarcoma	0.000483	0.00156	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—sarcoma	0.000482	0.00155	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—sarcoma	0.000479	0.00154	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—sarcoma	0.000471	0.00152	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—sarcoma	0.000468	0.00151	CcSEcCtD
Triazolam—CYP2C8—liver—sarcoma	0.000467	0.00742	CbGeAlD
Triazolam—Constipation—Doxorubicin—sarcoma	0.000464	0.00149	CcSEcCtD
Triazolam—Pain—Doxorubicin—sarcoma	0.000464	0.00149	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—sarcoma	0.000463	0.00149	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—sarcoma	0.000447	0.00144	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—sarcoma	0.000443	0.00143	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—sarcoma	0.000432	0.00139	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—sarcoma	0.000429	0.00138	CcSEcCtD
Triazolam—CYP3A5—liver—sarcoma	0.000421	0.0067	CbGeAlD
Triazolam—Asthenia—Epirubicin—sarcoma	0.000421	0.00135	CcSEcCtD
Triazolam—CYP2C9—liver—sarcoma	0.000415	0.00659	CbGeAlD
Triazolam—Pruritus—Epirubicin—sarcoma	0.000415	0.00134	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—sarcoma	0.000401	0.00129	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—sarcoma	0.0004	0.00129	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—sarcoma	0.000389	0.00125	CcSEcCtD
Triazolam—Dizziness—Epirubicin—sarcoma	0.000388	0.00125	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—sarcoma	0.000384	0.00124	CcSEcCtD
Triazolam—Vomiting—Epirubicin—sarcoma	0.000373	0.0012	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—sarcoma	0.000371	0.00119	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—sarcoma	0.000369	0.00119	CcSEcCtD
Triazolam—Headache—Epirubicin—sarcoma	0.000367	0.00118	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—sarcoma	0.000359	0.00115	CcSEcCtD
Triazolam—Nausea—Epirubicin—sarcoma	0.000348	0.00112	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—sarcoma	0.000345	0.00111	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—sarcoma	0.000342	0.0011	CcSEcCtD
Triazolam—Headache—Doxorubicin—sarcoma	0.00034	0.00109	CcSEcCtD
Triazolam—Nausea—Doxorubicin—sarcoma	0.000322	0.00104	CcSEcCtD
Triazolam—CYP3A4—liver—sarcoma	0.000316	0.00503	CbGeAlD
